Literature DB >> 518845

Amino acid sequence studies on the alpha chain of human fibrinogen. Exact location of cross-linking acceptor sites.

B A Cottrell, D D Strong, K W Watt, R F Doolittle.   

Abstract

Human fibrinogen was clotted under conditions that promote latent factor XIII activity and in the presence of a radioactive substitute cross-linking donor ([14C]glycine ethyl ester). The labeled fibrin was reduced and alkylated in the presence of 6 M guanidinium chloride. After dialysis and freeze-drying, the preparation was separated into its constituent polypeptide subunits by chromatography on (carboxymethyl)cellulose in the presence of 8 M urea. Under the incorporation conditions used, the radioactivity was limited to gamma chains (one donor molecule/chain) and alpha chains (two donor molecules/chain). The labeled alpha chains were digested with cyanogen bromide and fractionated on Sephadex G-50. All the radioactivity was found in a fragment previously designated H alpha CNI, the largest of the cyanogen bromide fragments in the alpha chain. The fragment was further fragmented by digestion with plasmin, trypsin, chymotrypsin, and/or staphylococcal protease. The incorporated radioactivity was found to reside in equal amounts at two different sites located 38 residues apart. These were determined to be positions 88 and 126 in H alpha CNI, which correspond to glutamine-328 and glutamine-366 in the alpha chain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518845     DOI: 10.1021/bi00591a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity.

Authors:  Y V Matsuka; S Pillai; S Gubba; J M Musser; S B Olmsted
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.

Authors:  C W Francis; V J Marder
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.

Authors:  Weixun Wang
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

4.  On the mechanism of αC polymer formation in fibrin.

Authors:  Galina Tsurupa; Igor Pechik; Rustem I Litvinov; Roy R Hantgan; Nico Tjandra; John W Weisel; Leonid Medved
Journal:  Biochemistry       Date:  2012-03-15       Impact factor: 3.162

5.  Location of peptide fragments in the fibrinogen molecule by immunoelectron microscopy.

Authors:  J N Telford; J A Nagy; P A Hatcher; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

Review 6.  Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots.

Authors:  Marissa Martinez; John W Weisel; Harry Ischiropoulos
Journal:  Free Radic Biol Med       Date:  2013-07-11       Impact factor: 7.376

7.  Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).

Authors:  Kelly Njine Mouapi; Lucille J Wagner; Chad A Stephens; Mohammed M Hindi; Daniel W Wilkey; Michael L Merchant; Muriel C Maurer
Journal:  Thromb Haemost       Date:  2019-05-05       Impact factor: 5.249

8.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113

9.  Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.

Authors:  Cédric Duval; Adomas Baranauskas; Tímea Feller; Majid Ali; Lih T Cheah; Nadira Y Yuldasheva; Stephen R Baker; Helen R McPherson; Zaher Raslan; Marc A Bailey; Richard M Cubbon; Simon D Connell; Ramzi A Ajjan; Helen Philippou; Khalid M Naseem; Victoria C Ridger; Robert A S Ariëns
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.